Figure 3.
External validation. (a) Colon cancer patients have higher hsa-miR-23a-3p levels in GSE112264. (b) Colon cancer patients have higher hsa-miR-663a levels in GSE112264. (c) ROC of a scoring system in GSE112264. (d) Colon cancer patients have higher hsa-miR-23a-3p levels in GSE106817. (e) Colon cancer patients have higher hsa-miR-663a levels in GSE106817. (f) ROC of a scoring system in GSE106817.